XSWX:MOLN (Switzerland)  
Molecular Partners AG logo

Molecular Partners AG

CHF 6.04 (-1.95%) Sep 23
P/E:
1.71
P/B:
0.74
Market Cap:
CHF 196.31M ($ 200.10M)
Enterprise V:
CHF -83.31M ($ -84.92M)
Volume:
27.91K
Avg Vol (2M):
58.99K
Also Trade In:
Volume:
27.91K
Market Cap CHF:
196.31M
Market Cap $:
200.10M
PE Ratio:
1.71
Avg Vol (2-Month):
58.99K
Enterprise Value CHF:
-83.31M
Enterprise Value $:
-84.92M
PB Ratio:
0.74
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Molecular Partners AG is a clinical stage biopharmaceutical company. The company focuses on the discovery, development and prospective commercialization of a new class of biopharmaceutical products. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
Name Current Vs Industry Vs History
Cash-To-Debt 52.35
Equity-to-Asset 0.89
Debt-to-Equity 0.02
Debt-to-EBITDA 0.05
Interest Coverage 163.84
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.1
Distress
Grey
Safe
Beneish M-Score 24.91
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 47.93
9-Day RSI 51.67
14-Day RSI 51.24
6-1 Month Momentum % -70.35
12-1 Month Momentum % -68.11

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.5
Quick Ratio 12.5
Cash Ratio 12.23
Days Sales Outstanding 16.64

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15

Financials (Next Earnings Date:2022-11-25 Est.)

XSWX:MOLN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 189.828
EPS (TTM) (CHF) 3.53
Beta 0.23
Volatility % 93.46
14-Day RSI 51.24
14-Day ATR (CHF) 0.324355
20-Day SMA (CHF) 5.857
12-1 Month Momentum % -68.11
52-Week Range (CHF) 5.27 - 28.9
Shares Outstanding (Mil) 32.5

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Molecular Partners AG Filings

Document Form Filing Date
No Filing Data

Molecular Partners AG Analysis

Share your research